CHARLOTTE, N.C. & HYDERABAD, India--(BUSINESS WIRE)--Vimta Labs announced today that it has completed its 1,000th clinical trial. This milestone reflects India’s growing importance in the pharmaceutical development industry, and Vimta’s growing dominance among India’s clinical research organizations (CRO). Considering Vimta’s track record of 25 years in operation, its no wonder that no other Indian CRO has done as many clinical studies.
